PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Protective effect of hydroxysafflor yellow A on bleomycin-induced pulmonary inflammation and fibrosis in rats.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29294256 ↗2018Reported benefit

Protective effect of hydroxysafflor yellow A on bleomycin-induced pulmonary inflammation and fibrosis in rats.

RatChemical/toxinWistarn = n=8 or 12 per group across 6 groupsIntraperitoneal35.6, 53.3 and 80.0 mg/kg/dayCommenced after bleomycin administration

Model: Bleomycin-induced acute lung inflammation and chronic pulmonary fibrosis

Hydroxysafflor yellow A ameliorated lung inflammation at day 7 and fibrosis at day 21, raised PaO2 and lowered PaCO2, and reduced TNF-alpha, IL-1beta and IL-6 mRNA and NF-kappaB p65-positive cell numbers at 53.3 and 80.0 mg/kg. At the same doses it attenuated the increases in TGF-beta1, alpha-SMA a…

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.